Scarica l'app Stockscreener
1.08
2.70%
-0.03
Precedente Chiudi:
$1.11
Aprire:
$1.12
Volume 24 ore:
355.12K
Relative Volume:
1.00
Capitalizzazione di mercato:
$23.29M
Reddito:
-
Utile/perdita netta:
$-8.29M
Rapporto P/E:
-1.5429
EPS:
-0.7
Flusso di cassa netto:
$-6.47M
1 W Prestazione:
-4.42%
1M Prestazione:
-9.24%
6M Prestazione:
-35.71%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$1.05
$1.13
Intervallo di 1 settimana:
$1.05
$1.21
Portata 52W:
$0.94
$2.2299
NanoViricides Inc Stock (NNVC) Company Profile
Nome
NanoViricides Inc
Settore
Industria
Telefono
203-937-6137
Indirizzo
1 Controls Drive, Shelton, CT
Confronta NNVC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NNVC
NanoViricides Inc
|
1.08 | 23.94M | 0 | -8.29M | -6.47M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-16 | Iniziato | Alliance Global Partners | Buy |
| 2015-02-11 | Iniziato | Midtown Partners | Strong Buy |
NanoViricides Inc Borsa (NNVC) Ultime notizie
NanoViricides, Inc. Has Filed its Quarterly ReportSubsequent Raise Has Fortified Fiscal Position - hattiesburgamerican.com
NanoViricides to Present at the 3rd Annual DealFlow Discovery Conference - chronicle-tribune.com
NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close - hattiesburgamerican.com
NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles - hattiesburgamerican.com
NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza WaveNV-387 is Effective Against H3N2 - naplesnews.com
ETF Watch: Should I hold or sell NanoViricides Inc nowJuly 2025 Chart Watch & AI Powered Market Entry Ideas - baoquankhu1.vn
Can NanoViricides Inc. continue delivering strong returnsInstitutional Holding Changes & Outstanding Investment Trading - bollywoodhelpline.com
Aug Momentum: Is NanoViricides Inc forming a bullish divergenceTrade Analysis Summary & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Support Test: Should I invest in NanoViricides Inc before earningsJuly 2025 PostEarnings & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Jobs Data: How much upside does NanoViricides Inc have2025 Bull vs Bear & Long-Term Capital Growth Strategies - baoquankhu1.vn
NanoViricides Highlights Need for Broad-Spectrum Antivirals During Severe Influenza Season - citybuzz -
NanoViricides highlights need for broad-spectrum antivirals amid severe flu season - Proactive financial news
San Gabriel Valley Tribune - FinancialContent
Options Flow: Will NanoViricides Inc. stock continue dividend increases2025 Winners & Losers & Short-Term Swing Trade Alerts - Bộ Nội Vụ
Market Recap: Can NanoViricides Inc NV3P stock sustain institutional flowsInflation Watch & Stock Portfolio Risk Control - Bộ Nội Vụ
After-Hours Rally: Zentalis, LifeMD, And NanoViricides Among Top Gainers - Nasdaq
Published on: 2026-01-10 19:47:32 - ulpravda.ru
Volume Summary: Will NanoViricides Inc NV3P stock outperform small cap peersJuly 2025 Chart Watch & Reliable Breakout Forecasts - moha.gov.vn
NanoViricides Has Received Approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo - patriotledger.com
Can NanoViricides Inc. stock outperform in 2025 bull marketJuly 2025 Weekly Recap & Reliable Price Action Trade Plans - Улправда
Can NanoViricides Inc. stock hit record highs againPortfolio Update Summary & Expert Curated Trade Setup Alerts - Улправда
Geopolitics Watch: How analysts rate NanoViricides Inc. stock todayInflation Watch & Fast Moving Stock Trade Plans - Улправда
Inflation Data: How SUNE stock reacts to inflationary pressuresJuly 2025 Summary & Verified Technical Trade Signals - moha.gov.vn
Can NanoViricides Inc. stock sustain market leadershipJuly 2025 Market Mood & Weekly Consistent Profit Watchlists - Улправда
How risky is NanoViricides Inc. stock nowJuly 2025 Snapshot & Advanced Swing Trade Entry Alerts - Улправда
Market Review: Is NanoViricides Inc. stock oversold or undervaluedQuarterly Trade Report & Low Drawdown Trading Strategies - ulpravda.ru
How analysts rate NanoViricides Inc. stock todayQuarterly Profit Report & Weekly Stock Breakout Alerts - Улправда
Can NanoViricides Inc. stock weather global recessionBull Run & Daily Profit Focused Screening - ulpravda.ru
Is NanoViricides Inc stock oversold or undervaluedMarket Growth Review & Reliable Entry Point Trade Alerts - Bộ Nội Vụ
Profit Recap: How risky is NanoViricides Inc stock nowJuly 2025 PreEarnings & Consistent Profit Alerts - Bộ Nội Vụ
NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd - thespectrum.com
NanoViricides Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close - coloradoan.com
NanoViricides to Present at the PODD 2025 Conference in Boston on October 27 - The Register-Guard
Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive - The Register-Guard
Hogs Drift in a Quiet Session - Barchart.com
Cotton Faces Pressure into the Close - Barchart.com
Wild Yangtze: Echoes of Life from the River’s Rare Species - Barchart.com
Stocks slip on Wall Street as 2025 winds down - Barchart.com
NanoViricides Inc Azioni (NNVC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):